Brief: Rubius Therapeutics Explores Strategic Alternatives & Leadership Changes
02/11/2022 20:32
Nov 2 (Reuters) - Rubius Therapeutics Inc RUBY.O :
* RUBIUS THERAPEUTICS ANNOUNCES PROCESS TO EXPLORE STRATEGIC
ALTERNATIVES AND LEADERSHIP CHANGES
* RUBIUS THERAPEUTICS INC - STRATEGIC ALTERNATIVES THAT WILL
BE
EVALUATED INCLUDE SALE OF ALL OR PART OF COMPANY OR A MERGER
* RUBIUS THERAPEUTICS INC - REDUCING ITS WORKFORCE BY 84%
* RUBIUS THERAPEUTICS INC - DANNIELLE APPELHANS TO BECOME
PRESIDENT AND CHIEF EXECUTIVE OFFICER
* RUBIUS THERAPEUTICS INC - ADDITIONAL LEADERSHIP CHANGES
INCLUDE
DEPARTURES OF PEPE CARMONA, CHIEF FINANCIAL OFFICER
Source text for Eikon: ID:nGNXjcZmH
Further company coverage: RUBY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rubius Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Apple, TCR2 Therapeutics, Silvergate Capital
Brief: Rubius Therapeutics Inc - Nasdaq Notified Co That Trading In Co's Stock Will Be Suspended Upon Opening Of Business On March 7, 2023
Brief: Rubius Therapeutics Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Rubius Therapeutics Inc expected to post a loss of 30 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Baidu, Boeing, Microsoft